تحديد هوية البكتيريا المعزولة من حالات تسوس الأسنان، والخراجات، والتهاب اللثة، ودراسة تأثير المضادات الحيوية عليها

[1] Poveda Roda R. , Bag ́an J. V., J. M. Sanchis Bielsa, and E. Carbonell Pastor, “Antibiotic use in dental practice: a review,” Medicina Oral, Patologıa Oral Y Cirugia ́ıa Bucal” (Internet), vol. 12, no. 3, pp. 186– 192, 2007.

[2] Almeid V. S. M a, J. Azevedo, H. F. Leal, A. T. L. Queiroz, H. P. da Silva Filho, and J. N. Reisro, “Bacterial diversity an prevalence

of antibiotic resistance genes in the oral mic - biome,” PLoS One, vol. 15, no. 9, 2020.

[3] Seymour R. A., “Antibiotics in dentistry-an update,” Dental Update, vol. 40, no. 4, pp. 319–322, 2013.

[4] Kuriyama T, E. G. Absi, D. W. Williams, and M. A. O. Lewis, “An outcome audit of the treatment of acute dent-alveolar

infection: impact of penicillin resistance,” British Dental Journal, vol. 198, no. 12, pp. 759–763, 2005.

[5] Kleinberg I. “A mixed-bacteria ecological approach to understanding the role of the oral bacteria in dental caries causation: an alternative to Streptococcus mutans and the specific-plaque hypothesis”. Critic Rev Oral Biol Med. 2002;13:108-25. dio: 10.1177/154411130201300202.

[6] Van Houte J, Lopman J, Kent R. “ The predominant cultivable flora of sound and carious human root surfaces”. J Dent Res. 1994;73:1727-34. doi: 10.1177/00220345940730110801.

[7] Suman E, Devrari JC, Umesh U, Paul S, Suprabha B, Kotian SM. “Effect of fluoride and chlorhexidine varnish on biofilm formation of Streptococcus mutans”. Int Res J Biol Sci. 2015;4:4-7.

[8] Simón-Soro A, Mira A. “Solving the etiology of dental caries”. Trends Microbiol. 2015;23:76-82. doi: 10.1016/j. tim.2014.10.010.

[9] Oda Y, Hayashi F, Okada M. “Longitudinal study of dental caries incidence associated with Streptococcus mutans and Streptococcus sobrinus in patients with intellectual disabilities”. BMC Oral Health. 2015;15:102.

[10] Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. “Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010”. Lancet. 2012;380:2163-96. doi: 10.1016/S0140- 6736(12)61729-2.

[11] WHO. “ International statistical classification of diseases and related health problems”: World Health Organization; 2004. Available at: http://www.who.int/classifications/icd/en/. Accessed April 27, 2018.

[12] Simmonds RS, Pearson L, Kennedy RC, Tagg JR. “Mode of action of a lysostaphin-like bacteriolytic agent produced by treptococcus zooepidemicus 4881”. Appl Environ Microbiol. 1996;62:4536-41.

[13] Simmonds RS, Simpson WJ, Tagg JR. “Cloning and sequence analysis of zooA, a Streptococcus zooepidemicus gene encoding a bacteriocinlike inhibitory substance having a domain structure similar to that of lysostaphin”. Gene. 1997;189:255-61. doi:10.1016/S0378- 1119(96)00859-1.

[14] Bascones Mart Inez A, J. Aguirre Ur ́ızar, A. Bermejo Fenoll et al., “Consensus statement on antimicrobial treatment of

odontogenic bacterial infections,” Medicina Oral Patolog ́ıa Oral y Cirugia Bucal, vol. 9, no. 5, pp. 369–376, 2004.

[15] Freitas D, L. Gonçalves, M. J. Coelho et al., “Prevalence of antibiotic (β-lactams, tetracycline, metronidazole, erythromycin)

resistance genes in periodontic infections,” Clin Res, vol. 5, pp. 1–4, 2019.

[16] Jayadev M, P. Karunakar, B. Vishwanath, S. S. Chinmayi, P. Siddhartha, and B. Chaitanya, “Knowledge and pattern of antibiotic and nonnarcotic analgesic prescription for pulpal and periapical pathologies-a survey among dentists,” Journal of Clinical and Diagnostic Research: JCDR, vol. 8, no. 7, 2014.

[17] Lafaurie G. I, L. A. Noriega, C. C. Torres et al., “Impact of antibiotic prophylaxis on the incidence, nature, magnitude, and duration of bacteremia associated with dental procedures: a systematic review,” The Journal of the American Dental Association, vol. 150, no. 11, 2019.

[18] Dar-Odeh N, O. A. Abu-Hammad, M. K. AlOmiri, A. S. Khraisat, and A. A. Shehabi, “Antibiotic prescribing practices by dentists: a review,” Therapeutics and Clinical Risk Management, vol. 6, p. 301, 2010.

[19] Halling F, A. Neff, P. Heymann, and T. Ziebart, “Trends in antibiotic prescribing by dental practitioners in Germany,” Journal of Cranio-Maxillofacial Surgery, vol. 45, no. 11, pp. 1854–1859, 2017.

[20] Robertson and A. J. Smith D, “The microbiology of the acute dental abscess,” Journal of Medical Microbiology, vol. 58, no. 2,

pp. 155–162, 2009.

[21] L ́opez-P ́ıriz, L. Aguilar R, and M. J. Gim ́enez, “Management of odontogenic infection of pulpal and periodontal origin,” Medicina Oral, Patologıa Oral y Cirugıa Bucal (Internet), vol. 12, no. 2, pp. 154–159, 2007.

[22] Jayadev M, P. Karunakar, B. Vishwanath, S. S. Chinmayi, P. Siddhartha, and B. Chaitanya, “Knowledge and pattern of antibiotic and no narcotic analgesic prescription for pulpal and periapical pathologies-a survey among dentists,” Journal of Clinical and Diagnostic Research: JCDR, vol. 8, no. 7, 2014.